AUROPHARMA.BOAUROPHARMA.BO
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$120.01B
↑ 47% above average
Average (9y)
$81.87B
Historical baseline
Range
High:$120.01B
Low:$56.32B
CAGR
+8.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $120.01B | +14.8% |
| 2024 | $104.50B | +28.9% |
| 2023 | $81.05B | +3.8% |
| 2022 | $78.06B | -17.0% |
| 2021 | $94.03B | +7.2% |
| 2020 | $87.75B | +25.6% |
| 2019 | $69.88B | +5.5% |
| 2018 | $66.24B | +8.8% |
| 2017 | $60.86B | +8.1% |
| 2016 | $56.32B | - |